Manufacturers brewing new swine flu vaccine
Washington: Attention is shifting to the world`s five leading flu vaccine makers: How fast are they really producing swine flu vaccine, and just how do they plan to test that it works?
A meeting Thursday of the Food and Drug Administration`s scientific advisers offers the first in-depth public progress report since U.S. scientists delivered the novel virus to manufacturers and asked them to turn it into usable vaccine.
They`ve succeeded to a degree. The National Institutes of Health on Wednesday called for a few thousand volunteers, from babies to the elderly, for studies to see if pilot batches are safe and protective. The first shots should go into adult volunteers` arms in early August, with child studies to follow quickly if there are no signs of immediate side effects.
Those government-directed studies — and more that manufacturers will run — are key as the government decides whether to offer swine flu vaccine to millions of Americans starting in mid-October, besides vaccinating against the regular winter flu. Health authorities in other countries are looking to the U.S. studies, too, as they make their own plans.
Assuming the studies show the vaccine is OK, a big question is how much will be available and when. Last week, the World Health Organization warned that production is going slower than predicted, with the strains now in use yielding only about half as much of the main vaccine ingredient as is usual.
Wednesday, London-based GlaxoSmithKline echoed that caution, saying it is "working as quickly as possible" but being hindered by those low yields.
"Some of us are skeptical that very much will be available by mid-October," said Dr. William Schaffner, a vaccine specialist at Vanderbilt University.
And the government has warned that any vaccination campaign will put higher-risk people in line for the first batches, as supplies gradually increase over time.
Manufacturers` vaccine studies are expected to largely mirror the NIH`s plans: Volunteers will get two vaccinations, 21 days apart. By early September, the NIH should have blood tests showing how much immune protection the initial inoculation triggered, and if a low-dose or higher-dose version was needed. It will take another month to get information on the second inoculation.
Complicating the question: If plain vaccine doesn`t spur enough protection or there isn`t enough supply, manufacturers could add immune-system boosters called adjuvants. That will pose a dilemma as the U.S. has never approved a flu vaccine containing those ingredients, although they are widely used in vaccine given to older adults in Europe.
But there`s little information on their safety in children and pregnant women. Dr. Anthony Fauci, the NIH`s infectious disease chief, said it`s highly unlikely that flu vaccine with an adjuvant would be part of a children`s immunization campaign. Part of FDA`s debate Thursday, however, is how to do additional testing of that combination in various age groups.
The NIH`s first studies will use flu shots made by France-based Sanofi-Pasteur and CSL Ltd., which on Wednesday began a much smaller study of its vaccine in its home country of Australia.
Also yet to be studied are shots made by Glaxo and Swiss-based Novartis, and a nasal-spray flu vaccine from Maryland-based MedImmune.
More from India
More from World
More from Sports
More from Entertaiment
- I eat beef, can somebody stop me?: Kiren Rijiju hits back at Naqvi
- Zee Media's mega survey on Modi govt
- Delhi: Visually impaired boy scores 91.4% in CBSE 12th Board exams
- MP: 14-year-old boy works as bonded labour since 2009
- UP: Man chops off wife's nose, hair for dowry
- Zee Media Exclusive: The plight of yoga expert Tejaswi Sharma
- Woman denied flat in Mumbai for being a Muslim
- 4 Indians in Forbes' 100 most powerful women list
- BBV: What challenges lie ahead of Modi govt?
- Gujjar stir: HC asks Rajasthan govt to clear rail track, roads
- DNA analysis of rising water crisis in India!
- DNA: Delhi shop owners express their plight through Zee initiative 'My News'
- Watch: Zee Media mega survey on Modi govt- Part 2
- Gujjar stir: HC asks Rajasthan govt to clear rail track, roads- Part II
- Heatwave continues in India, death toll climbs to over 1,400
- CBSE Class 10 Board Result 2015 to be announced today
- CBSE Class 10 Board Result 2015 (cbse.nic.in, cbseresults.nic.in) postponed?
- Check mahresult.nic.in for MSBSHSE Maharashtra Class 12 HSC Result 2015
- Maharashtra MSBSHSE HSC Result 2015 on mahresult.nic.in
- I was misquoted, says Kiren Rijiju on 'beef' remark
- First look: Salman Khan steals thunder in `Bajrangi Bhaijaan`
- mahresult.nic.in updated with MSBSHSE Maharashtra HSC Class XII Result 2015
- Manmohan Singh defends himself on 2G charge, slams Modi govt for 'carbon copy' schemes
- Check cbse.nic.in, cbseresults.nic.in for CBSE Class 10 Result 2015
- Sonia Gandhi 'unconstitutional authority' during UPA: PM Narendra Modi
- Hours after attacking NDA govt, Manmohan Singh meets PM Narendra Modi
- Reservation stir: Five percent job quota to Gujjars unlikely, hints Rajasthan govt
- PMO website revamped, now send e-mail to PM Modi directly
- Death toll climbs to over 1400 as intense heatwave continues in India
- CBSE Class 10 (Class X Board) Result 2015 on cbse.nic.in, cbseresults.nic.in at 2 pm